Last reviewed · How we verify
Aphthous ulcer of mouth — Treatment Landscape & Competitive Intelligence
4 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
| Drug | Generic | Sponsor | Class | Target | Line of therapy | First approval |
|---|---|---|---|---|---|---|
| Amoxanox | AMLEXANOX | Uluru | amlexanox | Inhibitor of nuclear factor kappa-B kinase subunit epsilon | 1996-01-01 | |
| Cortef | hydrocortisone | Generic (originally Merck/Upjohn) | Corticosteroid [EPC] | Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible | 1952-01-01 | |
| SULFUR | SULFUR | Poythress | sulfur | Carbonic anhydrase 1 | 1940-01-01 | |
| Cortisol | Cortisol | University of Zurich | Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible |
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- · 2 drugs in Aphthous ulcer of mouth
- Generic (originally Merck/Upjohn) · 1 drug in Aphthous ulcer of mouth
- Poythress · 1 drug in Aphthous ulcer of mouth
- Uluru · 1 drug in Aphthous ulcer of mouth
- University of Zurich · 1 drug in Aphthous ulcer of mouth
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in Aphthous ulcer of mouth:
- Aphthous ulcer of mouth treatment updates — RSS
- Aphthous ulcer of mouth treatment updates — Atom
- Aphthous ulcer of mouth treatment updates — JSON
Cite this brief
Drug Landscape (2026). Aphthous ulcer of mouth — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/aphthous-ulcer-of-mouth. Accessed 2026-06-10.
Related
- Aphthous ulcer of mouth full disease profile — treatment pathway, diagnostics, guidelines
- Browse all CI briefs
- Build a custom feed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing